logo

For the Inventor, By the Inventor

Iowa City, IA, United States of America

Paul B McCray, Jr

This inventor holds 15 USPTO granted patents and 6 published patent applications. Top assignees: University of Iowa Research Foundation, Chiron Corporation, Iowa State University Research Foundation Inc.. Active years: 2004-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul B McCray, Jr. Retrieved from https://idiyas.com/inventor/paul-b-mccray-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 

% Patents Active = 46.7

Average Co-Inventor Count = 3.8

ph-index = 4

Forward Citations = 165(Granted Patents)


Company Filing History:

goldMedal15 out of 925 
 
University of Iowa Research Foundation
 patents
silverMedal1 out of 672 
 
Chiron Corporation
 patents
bronzeMedal1 out of 1,424 
 
Iowa State University Research Foundation Inc.
 patents
4. 1 out of 16,008 
 
University of California
 patents
where one patent can have more than one assignee

Years Active: 2004-2026

Loading Chart...
15 patents (USPTO):Explore Patents
1. 12703726 - COMPOSITIONS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS (2026-08-11),
2. 9987299 - Methods of improving RNAi in well-differentiated airway epithelia (2018-06-05),
3. 9272016 - Methods to enhance RNAi oligonucleotide delivery to respiratory epithelial cells (2016-03-01),
4. 9211347 - Method of delivering vectors to pancreas and lungs by cannulating the aorta (2015-12-15),
5. 7951781 - Methods and compositions related to PLUNC surfactant polypeptides (2011-05-31),
6. 7931893 - Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (LCMV) (2011-04-26),
7. 7687475 - RNA interference in respiratory epithelial cells (2010-03-30),
8. 7470777 - Compositions and methods related to modified retroviral vectors for restricted, site specific integration (2008-12-30),
9. 7439066 - Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (LCMV) (2008-10-21),
10. 7297786 - RNA interference in respiratory epitheial cells (2007-11-20),
11. 7160727 - [object Object] (2007-01-09),
12. 7135339 - Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (LCMV) (2006-11-14),
13. 7071293 - Alpha helical peptides with broad spectrum antimicrobial activity that are insensitive to salt (2006-07-04),
14. 6855549 - Methods and compositions for increasing the infectivity of gene transfer vectors (2005-02-15),
15. 6809181 - Human beta-defensin-3 (HBD-3), a highly cationic beta-defensin antimicrobial peptide (2004-10-26),

Title: The Inventor Paul B McCray, Jr: Revolutionizing Industries

Introduction: Paul B McCray, Jr is a distinguished inventor hailing from Iowa City, IA. His innovative spirit and dedication to progress have led to groundbreaking advancements in various industries.

Latest Patents: Paul B McCray, Jr holds several patents in the fields of renewable energy, sustainable agriculture, and medical technology, showcasing his versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Paul B McCray, Jr has worked tirelessly to bring his ideas to life. His contributions have not only improved existing technologies but have also paved the way for future innovations.

Collaborations: Throughout his career, Paul B McCray, Jr has collaborated with leading researchers, engineers, and industry experts to further develop his inventions. These partnerships have been instrumental in bringing his ideas from concept to reality.

Conclusion: Paul B McCray, Jr's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors. His impact on various industries is undeniable, making him a true pioneer in the world of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…